Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Assets Average (2019 - 2025)

Eton Pharmaceuticals (ETON) has disclosed Assets Average for 7 consecutive years, with $98.3 million as the latest value for Q4 2025.

  • Quarterly Assets Average rose 75.61% to $98.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $98.3 million through Dec 2025, up 75.61% year-over-year, with the annual reading at $84.1 million for FY2025, 55.97% up from the prior year.
  • Assets Average hit $98.3 million in Q4 2025 for Eton Pharmaceuticals, down from $103.1 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $103.1 million in Q3 2025 to a low of $22.3 million in Q3 2022.
  • Historically, Assets Average has averaged $42.5 million across 5 years, with a median of $30.9 million in 2021.
  • Biggest five-year swings in Assets Average: decreased 24.31% in 2022 and later surged 204.72% in 2025.
  • Year by year, Assets Average stood at $27.0 million in 2021, then decreased by 13.91% to $23.3 million in 2022, then skyrocketed by 35.91% to $31.6 million in 2023, then soared by 76.97% to $56.0 million in 2024, then soared by 75.61% to $98.3 million in 2025.
  • Business Quant data shows Assets Average for ETON at $98.3 million in Q4 2025, $103.1 million in Q3 2025, and $92.9 million in Q2 2025.